Literature DB >> 4627710

Short-lasting, competitive neuromuscular blocking activity in a series of azobis-arylimidazo-(1,2-a)-pyridinium dihalides.

L Bolger, R T Brittain, D Jack, M R Jackson, L E Martin, J Mills, D Poynter, M B Tyers.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4627710     DOI: 10.1038/238354a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  7 in total

1.  Sir David Jack: an extraordinary drug discoverer and developer.

Authors:  Clive Page; Patrick Humphrey
Journal:  Br J Clin Pharmacol       Date:  2013-05       Impact factor: 4.335

Review 2.  Proceedings: A new muscle relaxant-AH8165.

Authors:  C E Blogg; T M Savege; J C Simpson; L A Ross; B R Simpson
Journal:  Proc R Soc Med       Date:  1973-10

Review 3.  Pharmacokinetics in intravenous anaesthetic practice.

Authors:  P Duvaldestin
Journal:  Clin Pharmacokinet       Date:  1981 Jan-Feb       Impact factor: 6.447

Review 4.  Clinical pharmacokinetics of the non-depolarising muscle relaxants.

Authors:  M I Ramzan; A A Somogyi; J S Walker; C A Shanks; E J Triggs
Journal:  Clin Pharmacokinet       Date:  1981 Jan-Feb       Impact factor: 6.447

5.  The effect of ketamine upon depolarizing and non-depolarizing neuromuscular blockade in rabbit.

Authors:  L G Bogdan; S N Glisson; A A El-Etr
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

6.  Analytical model of some pharmacokinetic and pharmacodynamic properties of fazadinium in man.

Authors:  A A d'Hollander; C Delcroix; P Duvaldestin; D Henzel; E Coussaert; J M Desmonts
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

7.  Design, synthesis, evaluation and thermodynamics of 1-substituted pyridylimidazo[1,5-a]pyridine derivatives as cysteine protease inhibitors.

Authors:  Mohd Sajid Khan; Mohd Hassan Baig; Saheem Ahmad; Shapi Ahmad Siddiqui; Ashwini Kumar Srivastava; Kumar Venkatraman Srinivasan; Irfan A Ansari
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.